Sangart appoints three to leadership team

Friday, February 17, 2012 12:43 PM

Sangart, a privately held biopharmaceutical company focused on oxygen-therapeutic agents, has appointed three new members to its executive team.

Frank Booth, MA, MSc, BM, BCh, FACS, was appointed to chief medical officer. Booth has more than 20 years of experience as a trauma and critical care surgeon and as a clinical investigator. Previously he worked in clinical development roles at Novo Nordisk and Eli Lilly.

Mary Rose Keller was appointed vice president of clinical operations, responsible for the execution of all clinical programs, including sickle cell, trauma and future treatments at Sangart. She has more than 25 years of experience in clinical research and trial execution and has been involved with numerous, successful regulatory submissions for companies such as Agouron, Pfizer and Shire Pharmaceuticals.

Carmen Betancourt-Riche, MBA, was appointed vice president of regulatory affairs and quality assurance, overseeing the design and execution of Sangart's global regulatory and quality assurance strategy. She more than 34 years of drug development experience in the pharmaceutical industry and has held senior regulatory roles at BioMarin Pharmaceutical, Cerexa, Coulter Pharmaceuticals, Genentech, KaloBios Pharmaceuticals and VaxGen.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs